Picture of SymBio Pharmaceuticals logo

4582 — SymBio Pharmaceuticals News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: SymBio Pharmaceuticals -9-MTH parent results

Nov 6 (Reuters)-  
             SymBio Pharmaceuticals Limited  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to   
                Sep 30, 2015        Sep 30, 2014      Dec 31, 2015   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales             1.33                1.35              1.87       
                 (-1.2 pct)          (+1.9 pct)        (-4.3 pct)    
  Operating     loss 987 mln        loss 966 mln        loss 2.45    
  Recurring       loss 1.06         loss 940 mln        loss 2.48    
  Net             loss 1.06         loss 943 mln        loss 2.49    
  EPS          loss 32.71 yen      loss 30.80 yen    loss 68.61 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - SymBio Pharmaceuticals Limited.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on SymBio Pharmaceuticals

See all news